Search results
MD Anderson Research Highlights for April 24, 2024
Newswise· 5 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 4 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology company ...
Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases
BioPharma Dive via Yahoo Finance· 7 days agoNonetheless, several have drawn the interest of large pharmaceutical companies. Ipsen, for instance,...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 4 days agoThat could be why the first generation of radiopharmaceuticals were flops, Seth, the Actinium CEO,...
Review explores cutaneous manifestations of myelodysplastic syndrome
Medical Xpress· 7 days agoCutaneous manifestations of myelodysplastic syndrome (MDS) are described in a perspective piece...
ImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for...
Morningstar· 6 days agoImmunityBio Announces FDA Approval of ANKTIVA®, First-in-Class IL-15 Receptor Agonist for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Designated an FDA Breakthrough Therapy, the novel immunotherapy ANKTIVA activates the body’s natural killer
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 6 days agoFederated Hermes Inc. cut its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with ...
Arthritis linked to blood cancer mutations
Medical Xpress· 6 days agoThe research focused on seronegative rheumatoid arthritis, a sub-type of the more common rheumatoid arthritis (RA), that differs in the inconsistency of...
Study reveals insights into DDX41 protein's role in blood cancer pathogenesis
Medical Xpress· 6 days agoA study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...
Kura Oncology Gets Breakthrough Designation For Leukemia Therapy
Market Watch· 7 days agoThe San Diego-based biopharmaceutical company said the U.S. Food and Drug Administration had granted ziftomenib the status as a potential treatment for relapsed/refractory NPM1-mutant